As ER stress is an evolutionarily conserved process involved in numerous diseases, AGGF1 protein therapy may serve as a new treatment not only for cardiovascular diseases, but also for many other diseases associated with ER stress. The gene discussed is AGGF1; the disease is cardiovascular disorder.